Orthofix (NSDQ:OFIX) announced that it appointed Paul Gonsalves as the president of its global extremities business.
Gonsalves joins Lewisville, Texas-based Orthofix after previously serving as chief commercial officer at Integra LifeSciences (NSDQ:IART). He also served as senior VP of enterprise sales and corporate marketing at the medtech company.
Before his roles at Integra, Gonsalves served as senior VP and chief transformation officer with AccentCare and held the role of VP and GM of primary care at Novartis (NYSE:NVS), among a series of other roles including a handful at General Electric Healthcare (NYSE:GE).
In his new role, Gonsalves will also serve on the company’s executive leadership team while reporting to Orthofix president and CEO Jon Serbousek.
“Paul brings to Orthofix more than 30 years of industry experience and proven leadership that will both complement and strengthen our exceptional extremities management team,” Serbousek said in a news release. “Throughout his career, Paul has led global teams in the successful development and execution of innovative strategies focused on driving commercial optimization. I am confident his experience and relationships with surgeons and hospitals will enable us to build and accelerate this important area of our business.”
In addition to the role, as an inducement to enter into employment with Orthofix, Gonsalves was granted time-based restricted stock units totaling 10,624 shares of Orthofix common stock and a time-based non-qualified stock option award to purchase an aggregate of 32,945 shares of the company’s common stock.
“It is an honor to be chosen to lead this sector of the company’s business with its long-standing history and reputation as a leader in providing orthopedic extremity solutions to meet the needs of patients around the world,” Gonsalves said. “I look forward to working with the Orthofix leadership and extremities teams to continue to grow and expand the availability of these life-changing products.”